Description
RADIOPHARMACEUTICALS
First action · last action
2008-10-01 · 2008-10-01
Transactions
1
First transaction's obligation
$120,000
Base + all options value (sum of deltas)
$120,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
446110 · PHARMACIES AND DRUG STORES
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2008-10-01+$120,000= $120,000
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2008-10-01 | +$120,000 | $120,000 | RADIOPHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PNF5PJRFG3M7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24224N0372 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $141,413 | FY2024 |
| 36C24224D0034 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $0 | FY2024 |
| 36C24121P0036 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $54,969 | FY2021 |
| 36C24220N0017 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $274,002 | FY2020 |
| 36C24219N0102 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $235,055 | FY2019 |
| VA24217J2952 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $101,950 | FY2018 |
Other recipients under Q517 from 242-NETWORK CONTRACT OFFICE 02 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA52813P0043 | GOLD STANDARD, INC. | 242-NETWORK CONTRACT OFFICE 02 | $225,500 | FY2013 |
| VA52812P0381 | MC STRATEGIES, INC. | 242-NETWORK CONTRACT OFFICE 02 | $16,476 | FY2012 |
| VA52812P0377 | GOLD STANDARD, INC. | 242-NETWORK CONTRACT OFFICE 02 | $50,541 | FY2012 |
| VA528C06019 | ROCHE DIAGNOSTICS CORPORATION | 242-NETWORK CONTRACT OFFICE 02 | $122,279 | FY2010 |
| VA528P0189 | GOLD STANDARD, INC. | 242-NETWORK CONTRACT OFFICE 02 | $416,679 | FY2009 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA528C94114_3600_-NONE-_-NONE- · retrieved 2026-09-26.